Results 251 to 260 of about 1,472,414 (411)

Chemotherapy‐induced peripheral neuropathy: A current review

open access: yesAnnals of Neurology, 2017
N. Staff   +3 more
semanticscholar   +1 more source

Levodopa–Entacapone–Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease – Interim Analysis of the ELEGANCE Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss   +10 more
wiley   +1 more source

Diverse cell types establish a pathogenic immune environment in peripheral neuropathy. [PDF]

open access: yesJ Neuroinflammation
Choi J   +9 more
europepmc   +1 more source

Hereditary Spastic Paraplegia in Alberta: Lessons from a Well‐Defined Cohort Including the Indigenous Population

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hereditary spastic paraplegias (HSP) are rare disorders sharing common features of leg spasticity with gait impairment. Simple and complex forms are recognized; over 50% of cases remain unsolved genetically. Little is known about the genetics of HSP among Indigenous Peoples. Objectives To describe clinical, radiological, and genetic
Ekhlas Assaedi   +7 more
wiley   +1 more source

Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy. [PDF]

open access: yesJ Peripher Nerv Syst
Ponirakis G   +14 more
europepmc   +1 more source

Peripheral neuropathy associated with erythrophagocytic lymphohistiocytosis. [PDF]

open access: bronze, 1988
Bernard Boutin   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy